Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-25-003883
Filing Date
2025-05-15
Accepted
2025-05-15 16:34:37
Documents
2
Period of Report
2025-05-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 9893
2 POA - WEI LIN poaweilin1.txt EX-24 4080
  Complete submission text file 0001562180-25-003883.txt   15386
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Issuer) CIK: 0001860782 (see all company filings)

EIN.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ERASCA, INC. 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address
Wei Lin (Reporting) CIK: 0001872772 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40791 | Film No.: 25954310